Our staff hold a wide variety of knowledge and expertise.
We have more than 300 scientists and support members contributing to our world-class research. Dedicated teams work around the clock seeking new opportunities that can lead to novel drugs, vaccines and diagnostics, translating our research into tangible benefits for the global community. Ground-breaking translational research requires a host of exceptional people coupled with state-of-the-art facilities and equipment.
Our Leadership Team
Acting Executive Director
Professor Michael Jennings
Acting Deputy Director
Professor Kate Seib
General Manager
Dr Chris Davis
Our Research leaders
Principal Research Leaders
Distinguished Professor Mark von Itzstein AO
FAA FAHMS FRACI NHMRC Investigator L3
Cancer; Infectious Diseases; Metabolic Disease
Professor Michael Jennings
FAHMS FASM FAAM NHMRC Investigator L3
Infectious Diseases
Professor Michael Good AO
FTSE FAHMS NHMRC Investigator L3
Infectious Diseases
Professor Kate Seib
NHMRC Investigator L2
Infectious Diseases
Professor Carolyn Mountford
Post-Traumatic Stress Disorder; Cancer
Professor Nicolle H Packer
Cancer; Mass Spectrometry; Glycoproteomics
Professor Daniel Kolarich
Cancer, Disease Glycobiology, Glycomics, Glycoproteomics, Mass Spectrometry
Research Leaders
Professor Victoria Korolik
Associate Director (Education & Engagement)
Professor Johnson Mak FASM
Professor Joe Tiralongo
Associate Professor Thomas Haselhorst
Associate Professor Lara Herrero
Associate Professor Todd Houston
Associate Professor Milton Kiefel
Associate Professor Manisha Pandey
Associate Professor Danielle Stanisic
Associate Professor Erik Streed
Associate Professor Thomas Ve
ARC Future Fellow and NHMRC Investigator EL2